← Back to Search

Digital Risk Assessment for HIV Prevention (CHIPPER Trial)

N/A

Recruiting

Led By Jenell Coleman, MD MPH

Research Sponsored by Johns Hopkins University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

CHIPPER Trial Summary

This trialwill investigate if collecting digital info on HIV risks can help more women get the PrEP medication they need.

Who is the study for?

This trial is for cis-gender women aged 15-65 who are seeing their doctors for preventive care like well-woman exams. It's not for those who are pregnant with established prenatal care, living with HIV, or can't complete the electronic health form in English or Spanish.Check my eligibility

What is being tested?

The study is testing if using electronic medical and sexual history data to identify HIV risk can increase the use of PrEP (a medication to prevent HIV) during routine gynecologic visits.See study design

What are the potential side effects?

Since this trial focuses on the implementation of an electronic assessment tool rather than a drug, there aren't direct side effects from medications being studied. However, PrEP itself may have side effects such as nausea, headache, stomach pain, and weight loss.

CHIPPER Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adoption of Electronic History Form

Number of PrEP prescriptions written for each patient

CHIPPER Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Patient Level + MultilevelExperimental Treatment2 Interventions

Participants in the arm will receive the patient level and multi-level intervention

Group II: MultilevelExperimental Treatment1 Intervention

Participants in this arm will receive the multi-level intervention

Group III: Standard of CareActive Control1 Intervention

Participants in this arm will receive standard of care

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor

2,260 Previous Clinical Trials

14,819,610 Total Patients Enrolled

University of MichiganOTHER

1,796 Previous Clinical Trials

6,376,786 Total Patients Enrolled

National Institute of Mental Health (NIMH)NIH

2,784 Previous Clinical Trials

2,688,105 Total Patients Enrolled

Media Library

Patient Level + Multilevel Clinical Trial Eligibility Overview. Trial Name: NCT05412433 — N/A

HIV Prevention Research Study Groups: Standard of Care, Patient Level + Multilevel, Multilevel

HIV Prevention Clinical Trial 2023: Patient Level + Multilevel Highlights & Side Effects. Trial Name: NCT05412433 — N/A

Patient Level + Multilevel 2023 Treatment Timeline for Medical Study. Trial Name: NCT05412433 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to partake in this clinical experiment?

"This trial is recruiting 1170 participants between 15 and 65 years old. Accordingly, all candidates must meet the age criteria to be eligible for enrollment."

Answered by AI

How many participants have so far been recruited for this medical research project?

"Affirmative. Clinicaltrials.gov conveys that this clinical trial, which was initially posted on October 3rd 2022, is still recruiting participants across one location for a total of 1170 patients."

Answered by AI

Can octogenarians participate in this research?

"In accordance with the aforementioned standards, this clinical trial requires all participants to be between 15 and 65 years old."

Answered by AI

Could eligible individuals still participate in this research endeavor?

"Absolutely. According to the information stored on clinicaltrials.gov, this medical investigation is actively seeking participants and opened recruitment on October 3rd 2022. The trial demands 1170 patients recruited from a single site with edits made as recent as October 14th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Clinic-based HIV Identification and Prevention Project Using Electronic Resources

2022. "Clinic-based HIV Identification and Prevention Project Using Electronic Resources". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05412433.